XEROX HOLDINGS CORP (XRX) 14 +0.16 (+1.16%)
14 +0.16 (+1.16%)
US98421M1062 - Common Stock - Premarket: 13.95 -0.05 (-0.36%)
Fundamental Rating
Overall XRX gets a fundamental rating of 2 out of 10. We evaluated XRX against 35 industry peers in the Technology Hardware, Storage & Peripherals industry. Both the profitability and financial health of XRX have multiple concerns. XRX is not valued too expensively and it also shows a decent growth rate.
Profitability
Profitability Rating
XRX has a Piotroski-F score of 5.00. This indicates an average health and profitability for XRX.
The profitability ratios for XRX are negative, so there is not much use analyzing them.
XRX has a Return On Assets of -5.26%. This is below the industry average of 4.15%.
XRX has a Profit Margin of -9.28%. This is below the industry average of 5.26%.
VS Industry
ROA (-5.26%) VS Industry: 35% outperformed.
-104.91
45.27
Profit Margin (-9.28%) VS Industry: 27% outperformed.
-1,470.75
43.08
Valuation
Valuation Rating
With a Forward Price/Earnings Ratio of 7.82, the valuation of XRX can be described as cheap.
With a price book ratio of 0.53, XRX is valued rather cheaply.
Compared to an average industry price book ratio of 1.21, XRX is valued rather cheaply. On top of this, XRX is cheaper than 92% of the companies listed in the same industry.
The Price/Earnings Ratio is 16.87, which indicates a correct valuation of XRX.
Compared to an average industry Price/Earning Ratio of 11.04, XRX is valued slightly more expensive.
Compared to an average industry Enterprise Value to EBITDA ratio of 7.97, XRX is valued more expensive than its industry peers.
VS Industry
Price/Earnings (16.87) VS Industry: 31% outperformed.
242.83
1.39
Price/Book (0.53) VS Industry: 92% outperformed.
108.27
0.34
Enterprise Value/ EBITDA (11.41) VS Industry: 35% outperformed.
62.51
0.37
Growth
Growth Rating
The Earnings Per Share is expected to grow by 26.84% on average over the next 5 years. This is a very strong growth
When comparing the EPS growth rate of the last 5 years to the growth rate of the upcoming 5 years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last 5 years to the growth rate of the upcoming 5 years, we see that the growth is accelerating.
XRX shows a decrease in Revenue. In the last year, the revenue decreased by -3.47%.
The Revenue has been decreasing by -8.16% on average over the past 5 years.
XRX is expected to show a decrease in Revenue. In the coming 5 years, the Revenue will decrease by -0.27% yearly.
XRX shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -52.57%.
The earnings per share for XRX have been decreasing by -18.35% on average. This is quite bad
| Past | Future | ||||||
|---|---|---|---|---|---|---|---|
| 5Y | 3Y | 1Y | 1Y | 2Y | 3Y | 5Y | |
| EPS | -18.35% | -24.22% | -52.57% | -30.87% | 8.92% | 14.38% | 26.84% |
| Revenue | -8.16% | -10.02% | -3.47% | 0.17% | 0.06% | -0.03% | -0.27% |
Health
Health Rating
XRX has a Current Ratio of 1.20. This is a normal value and indicates that XRX is financially healthy and should not expect problems in meeting its short term obligations.
XRX has a Piotroski-F score of 5.00. This indicates an average health and profitability for XRX.
Compared to an average industry Current Ratio of 1.99, XRX is worse placed to pay its short term obligations than its industry peers.
XRX has a Quick Ratio of 1.20. This is a bad value and indicates that XRX is not financially healthy enough and could expect problems in meeting its short term obligations.
Compared to an average industry Quick Ratio of 1.29, XRX is worse placed to pay its short term obligations than its industry peers.
Compared to an average industry Debt to Equity Ratio of 0.01, XRX is requires more financing than its industry peers. 89% of its industry peers have a better Debt to Equity Ratio.
XRX has an Altman-Z score of 1.26. This is a bad value and indicates that XRX is not financially healthy and even has some risk of bankruptcy.
Compared to an average industry Altman-Z score of 2.15, XRX is in worse financial health than its industry peers.
VS Industry
Debt/Equity (0.68) VS Industry: 11% outperformed.
46.44
0.00
Quick Ratio (0.98) VS Industry: 35% outperformed.
0.37
36.24
Current Ratio (1.2) VS Industry: 29% outperformed.
0.48
36.70
Altman-Z (1.26) VS Industry: 36% outperformed.
-10.30
23.44
Dividend
Dividend Rating
With a Yearly Dividend Yield of 6.17%, XRX is a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 3.48, XRX pays a better dividend. On top of this XRX pays more dividend than 100% of the companies listed in the same industry.
XRX's Dividend Yield is rather good when compared to the S&P500 average which is at 2.48.
XRX has paid a dividend for at least 10 years, which is a reliable track record.
XRX has negative earnings and hence a negative payout ratio. The dividend may be in danger.
VS Industry
Dividend Yield (6.17%) VS Industry: 100% outperformed.
0.61
6.17
XEROX HOLDINGS CORP14
NASDAQ:XRX (9/27/2022, 7:23:37 PM)+0.16 (+1.16%)
| GICS Sector | Information Technology | ||
| GICS IndustryGroup | Technology Hardware & Equipment | ||
| GICS Industry | Technology Hardware, Storage & Peripherals | ||
| Earnings (Last) | 07-26 2022-07-26/bmo | Earnings (Next) | 10-24 2022-10-24 |
| Ins Owners | 0.81% | Inst Owners | 96.05% |
| Market Cap | 2.18B | Analysts | 44 |
| PE | 16.87 | Fwd PE | 7.82 |
| PEG (NY) | N/A | PEG (5Y) | N/A |
| P/S | 0.31 | P/B | 0.53 |
| EV/EBITDA | 11.41 | ||
| Dividend Yield | 6.17% | Dividend Growth | N/A |
| DP | -28.84% | Ex-Date | 09-29 2022-09-29 (0.25) |
| EPS 1Y | -52.57% | EPS 3Y | -24.22% |
| EPS 5Y | -18.35% | EPS growth Q2Q | -72.34% |
| EPS Next Y | -30.87% | EPS Next 2Y | 8.92% |
| EPS Next 3Y | 14.38% | EPS Next 5Y | 26.84% |
| Revenue growth 1Y | -3.47% | Revenue growth 3Y | -10.02% |
| Revenue growth 5Y | -8.16% | Revenue growth Q2Q | -2.57% |
| Revenue Next Year | 0.17% | Revenue Next 2Y | 0.06% |
| Revenue Next 3Y | -0.03% | Revenue Next 5Y | -0.27% |
| Current Ratio | 1.2 | Quick Ratio | 0.98 |
| Altman-Z | 1.26 | F-Score | 5 |
| Debt/Equity | 0.68 | ||
| ROA | -5.26% | ROE | N/A |
| ROIC | 1.89% | ROICg | 1.15% |
| PM | -9.28 | OM | 1.97 |
| Asset Turnover | 0.57 | ||
Fundamental Stock Screener Links
Fundamental Stock Screener
Find stocks with similar Fundamental rating on the USA
Best Fundamental Competitors Stock Screener
Find the competitors with the best fundamentals on the USA
Best Valuation Competitors Stock Screener
Find the competitors with the best valuation on the USA
Best Dividend Competitors Stock Screener
Find the competitors with the best dividend on the USA